CURRENT OPINION IN HEMATOLOGY

PIK3CA mutations in vascular malformations

Rapamycin and treatment of venous malformations.

Altered functions of platelets during aging.

Mechanisms of leukemic transformation in congenital neutropenia

p53 involvement in clonal hematopoiesis of indeterminate potential.

Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?

The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas.

Outpatient induction and consolidation care strategies in acute myeloid leukemia

Toll-like receptor signaling in hematopoietic stem and progenitor cells.

CADASIL: new advances in basic science and clinical perspectives

The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics

Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia

Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells.

Normal and leukemic stem cell niche interactions.

Luke Fletcher, md1,2 and uma borate, md1,2.

Using genomic data for selecting the treatment of lymphoma patients.

Emerging molecular mechanisms of vascular dementia

A somatic missense mutation in GNAQ causes capillary malformation

Oxidation and erythropoiesis

Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia

Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Banking with precision: transfusion medicine as a potential universal application in clinical genomics.

Bone morphogenetic protein and blood vessels: new insights into endothelial cell junction regulation

Application of stem cell transplantation to autoimmune diseases.

Does fibrinogen serve the host or the microbe in Staphylococcus infection?

Transcription factor and cytokine regulation of eosinophil lineage commitment.

Which patients with acute myeloid leukemia in CR1 can be spared an allogeneic transplant?

Posttransplant maintenance therapy for acute leukemias

Current landscape for chimeric antigen receptor T cells in lymphomas.

Antiphospholipid syndrome in pediatric patients.

Hypomethylating agents with venetoclax: have we discovered the holy grail?

The controversial role of red cell transfusions for sickle cell pain.

Recent advances in inherited platelet disorders.

Current state of nonengrafting donor leukocyte infusion (focus on microtransplantation for acute myeloid leukemia).

MICROtransplant to refractory acute myeloid leukemia in Egyptian population.

Detection and management of acute myeloid leukemia measurable residual disease: is it standard of care?

Hematopoietic stem cells: self-renewal and expansion.

Defining the functions of adenosine-to-inosine RNA editing through hematology.

Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemia

Strategies for managing transfusional iron overload: conventional treatments and novel strategies

Activated protein C in neuroprotection and malaria.

Is autologous stem cell transplantation still relevant for multiple myeloma?

Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia.

Editorial introduction.

Growing old in the age of heterogeneity: the perils of shifting clonality.

Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.